The global market for Macrolide Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The macrolide drugs are a group of antibiotics produced by various strains of Streptomyces (spore forming bacteria that grow slowly in soil or water as a branching filamentous mycelium similar to that of fungi) and have a complex chemical (macrocyclic) structure. They act by inhibiting protein synthesis, specifically by blocking the 50S ribosomal subunit. They are broad spectrum antibiotics.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Macrolide Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Macrolide Drugs.

The Macrolide Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Macrolide Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Macrolide Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Macrolide Drugs Market Report

Report Metric	Details
Report Name	Macrolide Drugs Market
CAGR	5%
Segment by Type	14-Membered Ring Agents 15-Membered Ring Agents 16-Membered Ring Agents Ketolides
Segment by Application	Hospitals Clinics Hospitalshospital Pharmacies Retail Pharmacies Online Pharmacies
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Abbott Laboratories, Akorn, Eli Lilly & Co., Fresenius Kabi, Gland Pharmm, Sirolimus, Neo Química, Tacorolimus, Macrolide Pharmaceuticals, Mylan, Pfizer, Sanofi, Merck & Co., Sandoz International, Teva Pharmaceutical Industries, WOCKHARDT
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Macrolide Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Macrolide Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Macrolide Drugs Market report?

Ans: The main players in the Macrolide Drugs Market are Abbott Laboratories, Akorn, Eli Lilly & Co., Fresenius Kabi, Gland Pharmm, Sirolimus, Neo Química, Tacorolimus, Macrolide Pharmaceuticals, Mylan, Pfizer, Sanofi, Merck & Co., Sandoz International, Teva Pharmaceutical Industries, WOCKHARDT

What are the Application segmentation covered in the Macrolide Drugs Market report?

Ans: The Applications covered in the Macrolide Drugs Market report are Hospitals, Clinics, Hospitalshospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Macrolide Drugs Market report?

Ans: The Types covered in the Macrolide Drugs Market report are 14-Membered Ring Agents, 15-Membered Ring Agents, 16-Membered Ring Agents, Ketolides

1 Macrolide Drugs Market Overview

1.1 Product Definition

1.2 Macrolide Drugs by Type

1.2.1 Global Macrolide Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 14-Membered Ring Agents

1.2.3 15-Membered Ring Agents

1.2.4 16-Membered Ring Agents

1.2.5 Ketolides

1.3 Macrolide Drugs by Application

1.3.1 Global Macrolide Drugs Market Value by Application (2024 VS 2031)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Hospitalshospital Pharmacies

1.3.5 Retail Pharmacies

1.3.6 Online Pharmacies

1.4 Global Macrolide Drugs Market Size Estimates and Forecasts

1.4.1 Global Macrolide Drugs Revenue 2020-2031

1.4.2 Global Macrolide Drugs Sales 2020-2031

1.4.3 Global Macrolide Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Macrolide Drugs Market Competition by Manufacturers

2.1 Global Macrolide Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Macrolide Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Macrolide Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Macrolide Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Macrolide Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Macrolide Drugs, Product Type & Application

2.7 Global Key Manufacturers of Macrolide Drugs, Date of Enter into This Industry

2.8 Global Macrolide Drugs Market Competitive Situation and Trends

2.8.1 Global Macrolide Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Macrolide Drugs Players Market Share by Revenue

2.8.3 Global Macrolide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Macrolide Drugs Market Scenario by Region

3.1 Global Macrolide Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Macrolide Drugs Sales by Region: 2020-2031

3.2.1 Global Macrolide Drugs Sales by Region: 2020-2025

3.2.2 Global Macrolide Drugs Sales by Region: 2026-2031

3.3 Global Macrolide Drugs Revenue by Region: 2020-2031

3.3.1 Global Macrolide Drugs Revenue by Region: 2020-2025

3.3.2 Global Macrolide Drugs Revenue by Region: 2026-2031

3.4 North America Macrolide Drugs Market Facts & Figures by Country

3.4.1 North America Macrolide Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Macrolide Drugs Sales by Country (2020-2031)

3.4.3 North America Macrolide Drugs Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Macrolide Drugs Market Facts & Figures by Country

3.5.1 Europe Macrolide Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Macrolide Drugs Sales by Country (2020-2031)

3.5.3 Europe Macrolide Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Macrolide Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Macrolide Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Macrolide Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific Macrolide Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Macrolide Drugs Market Facts & Figures by Country

3.7.1 Latin America Macrolide Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Macrolide Drugs Sales by Country (2020-2031)

3.7.3 Latin America Macrolide Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Macrolide Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Macrolide Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Macrolide Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Macrolide Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Macrolide Drugs Sales by Type (2020-2031)

4.1.1 Global Macrolide Drugs Sales by Type (2020-2025)

4.1.2 Global Macrolide Drugs Sales by Type (2026-2031)

4.1.3 Global Macrolide Drugs Sales Market Share by Type (2020-2031)

4.2 Global Macrolide Drugs Revenue by Type (2020-2031)

4.2.1 Global Macrolide Drugs Revenue by Type (2020-2025)

4.2.2 Global Macrolide Drugs Revenue by Type (2026-2031)

4.2.3 Global Macrolide Drugs Revenue Market Share by Type (2020-2031)

4.3 Global Macrolide Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Macrolide Drugs Sales by Application (2020-2031)

5.1.1 Global Macrolide Drugs Sales by Application (2020-2025)

5.1.2 Global Macrolide Drugs Sales by Application (2026-2031)

5.1.3 Global Macrolide Drugs Sales Market Share by Application (2020-2031)

5.2 Global Macrolide Drugs Revenue by Application (2020-2031)

5.2.1 Global Macrolide Drugs Revenue by Application (2020-2025)

5.2.2 Global Macrolide Drugs Revenue by Application (2026-2031)

5.2.3 Global Macrolide Drugs Revenue Market Share by Application (2020-2031)

5.3 Global Macrolide Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Abbott Laboratories

6.1.1 Abbott Laboratories Company Information

6.1.2 Abbott Laboratories Description and Business Overview

6.1.3 Abbott Laboratories Macrolide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Abbott Laboratories Macrolide Drugs Product Portfolio

6.1.5 Abbott Laboratories Recent Developments/Updates

6.2 Akorn

6.2.1 Akorn Company Information

6.2.2 Akorn Description and Business Overview

6.2.3 Akorn Macrolide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Akorn Macrolide Drugs Product Portfolio

6.2.5 Akorn Recent Developments/Updates

6.3 Eli Lilly & Co.

6.3.1 Eli Lilly & Co. Company Information

6.3.2 Eli Lilly & Co. Description and Business Overview

6.3.3 Eli Lilly & Co. Macrolide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Eli Lilly & Co. Macrolide Drugs Product Portfolio

6.3.5 Eli Lilly & Co. Recent Developments/Updates

6.4 Fresenius Kabi

6.4.1 Fresenius Kabi Company Information

6.4.2 Fresenius Kabi Description and Business Overview

6.4.3 Fresenius Kabi Macrolide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Fresenius Kabi Macrolide Drugs Product Portfolio

6.4.5 Fresenius Kabi Recent Developments/Updates

6.5 Gland Pharmm

6.5.1 Gland Pharmm Company Information

6.5.2 Gland Pharmm Description and Business Overview

6.5.3 Gland Pharmm Macrolide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Gland Pharmm Macrolide Drugs Product Portfolio

6.5.5 Gland Pharmm Recent Developments/Updates

6.6 Sirolimus

6.6.1 Sirolimus Company Information

6.6.2 Sirolimus Description and Business Overview

6.6.3 Sirolimus Macrolide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Sirolimus Macrolide Drugs Product Portfolio

6.6.5 Sirolimus Recent Developments/Updates

6.7 Neo Química

6.7.1 Neo Química Company Information

6.7.2 Neo Química Description and Business Overview

6.7.3 Neo Química Macrolide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Neo Química Macrolide Drugs Product Portfolio

6.7.5 Neo Química Recent Developments/Updates

6.8 Tacorolimus

6.8.1 Tacorolimus Company Information

6.8.2 Tacorolimus Description and Business Overview

6.8.3 Tacorolimus Macrolide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Tacorolimus Macrolide Drugs Product Portfolio

6.8.5 Tacorolimus Recent Developments/Updates

6.9 Macrolide Pharmaceuticals

6.9.1 Macrolide Pharmaceuticals Company Information

6.9.2 Macrolide Pharmaceuticals Description and Business Overview

6.9.3 Macrolide Pharmaceuticals Macrolide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Macrolide Pharmaceuticals Macrolide Drugs Product Portfolio

6.9.5 Macrolide Pharmaceuticals Recent Developments/Updates

6.10 Mylan

6.10.1 Mylan Company Information

6.10.2 Mylan Description and Business Overview

6.10.3 Mylan Macrolide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Mylan Macrolide Drugs Product Portfolio

6.10.5 Mylan Recent Developments/Updates

6.11 Pfizer

6.11.1 Pfizer Company Information

6.11.2 Pfizer Description and Business Overview

6.11.3 Pfizer Macrolide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Pfizer Macrolide Drugs Product Portfolio

6.11.5 Pfizer Recent Developments/Updates

6.12 Sanofi

6.12.1 Sanofi Company Information

6.12.2 Sanofi Description and Business Overview

6.12.3 Sanofi Macrolide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Sanofi Macrolide Drugs Product Portfolio

6.12.5 Sanofi Recent Developments/Updates

6.13 Merck & Co.

6.13.1 Merck & Co. Company Information

6.13.2 Merck & Co. Description and Business Overview

6.13.3 Merck & Co. Macrolide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Merck & Co. Macrolide Drugs Product Portfolio

6.13.5 Merck & Co. Recent Developments/Updates

6.14 Sandoz International

6.14.1 Sandoz International Company Information

6.14.2 Sandoz International Description and Business Overview

6.14.3 Sandoz International Macrolide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Sandoz International Macrolide Drugs Product Portfolio

6.14.5 Sandoz International Recent Developments/Updates

6.15 Teva Pharmaceutical Industries

6.15.1 Teva Pharmaceutical Industries Company Information

6.15.2 Teva Pharmaceutical Industries Description and Business Overview

6.15.3 Teva Pharmaceutical Industries Macrolide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Teva Pharmaceutical Industries Macrolide Drugs Product Portfolio

6.15.5 Teva Pharmaceutical Industries Recent Developments/Updates

6.16 WOCKHARDT

6.16.1 WOCKHARDT Company Information

6.16.2 WOCKHARDT Description and Business Overview

6.16.3 WOCKHARDT Macrolide Drugs Sales, Revenue and Gross Margin (2020-2025)

6.16.4 WOCKHARDT Macrolide Drugs Product Portfolio

6.16.5 WOCKHARDT Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Macrolide Drugs Industry Chain Analysis

7.2 Macrolide Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Macrolide Drugs Production Mode & Process Analysis

7.4 Macrolide Drugs Sales and Marketing

7.4.1 Macrolide Drugs Sales Channels

7.4.2 Macrolide Drugs Distributors

7.5 Macrolide Drugs Customer Analysis

8 Macrolide Drugs Market Dynamics

8.1 Macrolide Drugs Industry Trends

8.2 Macrolide Drugs Market Drivers

8.3 Macrolide Drugs Market Challenges

8.4 Macrolide Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Macrolide Pharmaceuticals

Teva Pharmaceutical Industries

WOCKHARDT

List of Tables

Table 1. Global Macrolide Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Macrolide Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Macrolide Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Macrolide Drugs Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Macrolide Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Macrolide Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Macrolide Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Macrolide Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Macrolide Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Macrolide Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Macrolide Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Macrolide Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Macrolide Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Macrolide Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Macrolide Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Macrolide Drugs Sales by Region (2020-2025) & (K Units)

Table 18. Global Macrolide Drugs Sales Market Share by Region (2020-2025)

Table 19. Global Macrolide Drugs Sales by Region (2026-2031) & (K Units)

Table 20. Global Macrolide Drugs Sales Market Share by Region (2026-2031)

Table 21. Global Macrolide Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Macrolide Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global Macrolide Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Macrolide Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America Macrolide Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Macrolide Drugs Sales by Country (2020-2025) & (K Units)

Table 27. North America Macrolide Drugs Sales by Country (2026-2031) & (K Units)

Table 28. North America Macrolide Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Macrolide Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Macrolide Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Macrolide Drugs Sales by Country (2020-2025) & (K Units)

Table 32. Europe Macrolide Drugs Sales by Country (2026-2031) & (K Units)

Table 33. Europe Macrolide Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Macrolide Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Macrolide Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Macrolide Drugs Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Macrolide Drugs Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Macrolide Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Macrolide Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Macrolide Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Macrolide Drugs Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Macrolide Drugs Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Macrolide Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Macrolide Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Macrolide Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Macrolide Drugs Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Macrolide Drugs Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Macrolide Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Macrolide Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Macrolide Drugs Sales (K Units) by Type (2020-2025)

Table 51. Global Macrolide Drugs Sales (K Units) by Type (2026-2031)

Table 52. Global Macrolide Drugs Sales Market Share by Type (2020-2025)

Table 53. Global Macrolide Drugs Sales Market Share by Type (2026-2031)

Table 54. Global Macrolide Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Macrolide Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Macrolide Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global Macrolide Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global Macrolide Drugs Price (USD/Unit) by Type (2020-2025)

Table 59. Global Macrolide Drugs Price (USD/Unit) by Type (2026-2031)

Table 60. Global Macrolide Drugs Sales (K Units) by Application (2020-2025)

Table 61. Global Macrolide Drugs Sales (K Units) by Application (2026-2031)

Table 62. Global Macrolide Drugs Sales Market Share by Application (2020-2025)

Table 63. Global Macrolide Drugs Sales Market Share by Application (2026-2031)

Table 64. Global Macrolide Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Macrolide Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Macrolide Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global Macrolide Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global Macrolide Drugs Price (USD/Unit) by Application (2020-2025)

Table 69. Global Macrolide Drugs Price (USD/Unit) by Application (2026-2031)

Table 70. Abbott Laboratories Company Information

Table 71. Abbott Laboratories Description and Business Overview

Table 72. Abbott Laboratories Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Abbott Laboratories Macrolide Drugs Product

Table 74. Abbott Laboratories Recent Developments/Updates

Table 75. Akorn Company Information

Table 76. Akorn Description and Business Overview

Table 77. Akorn Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Akorn Macrolide Drugs Product

Table 79. Akorn Recent Developments/Updates

Table 80. Eli Lilly & Co. Company Information

Table 81. Eli Lilly & Co. Description and Business Overview

Table 82. Eli Lilly & Co. Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Eli Lilly & Co. Macrolide Drugs Product

Table 84. Eli Lilly & Co. Recent Developments/Updates

Table 85. Fresenius Kabi Company Information

Table 86. Fresenius Kabi Description and Business Overview

Table 87. Fresenius Kabi Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Fresenius Kabi Macrolide Drugs Product

Table 89. Fresenius Kabi Recent Developments/Updates

Table 90. Gland Pharmm Company Information

Table 91. Gland Pharmm Description and Business Overview

Table 92. Gland Pharmm Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Gland Pharmm Macrolide Drugs Product

Table 94. Gland Pharmm Recent Developments/Updates

Table 95. Sirolimus Company Information

Table 96. Sirolimus Description and Business Overview

Table 97. Sirolimus Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Sirolimus Macrolide Drugs Product

Table 99. Sirolimus Recent Developments/Updates

Table 100. Neo Química Company Information

Table 101. Neo Química Description and Business Overview

Table 102. Neo Química Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Neo Química Macrolide Drugs Product

Table 104. Neo Química Recent Developments/Updates

Table 105. Tacorolimus Company Information

Table 106. Tacorolimus Description and Business Overview

Table 107. Tacorolimus Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Tacorolimus Macrolide Drugs Product

Table 109. Tacorolimus Recent Developments/Updates

Table 110. Macrolide Pharmaceuticals Company Information

Table 111. Macrolide Pharmaceuticals Description and Business Overview

Table 112. Macrolide Pharmaceuticals Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. Macrolide Pharmaceuticals Macrolide Drugs Product

Table 114. Macrolide Pharmaceuticals Recent Developments/Updates

Table 115. Mylan Company Information

Table 116. Mylan Description and Business Overview

Table 117. Mylan Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Mylan Macrolide Drugs Product

Table 119. Mylan Recent Developments/Updates

Table 120. Pfizer Company Information

Table 121. Pfizer Description and Business Overview

Table 122. Pfizer Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. Pfizer Macrolide Drugs Product

Table 124. Pfizer Recent Developments/Updates

Table 125. Sanofi Company Information

Table 126. Sanofi Description and Business Overview

Table 127. Sanofi Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 128. Sanofi Macrolide Drugs Product

Table 129. Sanofi Recent Developments/Updates

Table 130. Merck & Co. Company Information

Table 131. Merck & Co. Description and Business Overview

Table 132. Merck & Co. Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 133. Merck & Co. Macrolide Drugs Product

Table 134. Merck & Co. Recent Developments/Updates

Table 135. Sandoz International Company Information

Table 136. Sandoz International Description and Business Overview

Table 137. Sandoz International Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 138. Sandoz International Macrolide Drugs Product

Table 139. Sandoz International Recent Developments/Updates

Table 140. Teva Pharmaceutical Industries Company Information

Table 141. Teva Pharmaceutical Industries Description and Business Overview

Table 142. Teva Pharmaceutical Industries Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 143. Teva Pharmaceutical Industries Macrolide Drugs Product

Table 144. Teva Pharmaceutical Industries Recent Developments/Updates

Table 145. WOCKHARDT Company Information

Table 146. WOCKHARDT Description and Business Overview

Table 147. WOCKHARDT Macrolide Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 148. WOCKHARDT Macrolide Drugs Product

Table 149. WOCKHARDT Recent Developments/Updates

Table 150. Key Raw Materials Lists

Table 151. Raw Materials Key Suppliers Lists

Table 152. Macrolide Drugs Distributors List

Table 153. Macrolide Drugs Customers List

Table 154. Macrolide Drugs Market Trends

Table 155. Macrolide Drugs Market Drivers

Table 156. Macrolide Drugs Market Challenges

Table 157. Macrolide Drugs Market Restraints

Table 158. Research Programs/Design for This Report

Table 159. Key Data Information from Secondary Sources

Table 160. Key Data Information from Primary Sources

Table 161. Authors List of This Report

List of Figures

Figure 1. Product Picture of Macrolide Drugs

Figure 2. Global Macrolide Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Macrolide Drugs Market Share by Type: 2024 & 2031

Figure 4. 14-Membered Ring Agents Product Picture

Figure 5. 15-Membered Ring Agents Product Picture

Figure 6. 16-Membered Ring Agents Product Picture

Figure 7. Ketolides Product Picture

Figure 8. Global Macrolide Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Macrolide Drugs Market Share by Application: 2024 & 2031

Figure 10. Hospitals

Figure 11. Clinics

Figure 12. Hospitalshospital Pharmacies

Figure 13. Retail Pharmacies

Figure 14. Online Pharmacies

Figure 15. Global Macrolide Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Macrolide Drugs Market Size (2020-2031) & (US$ Million)

Figure 17. Global Macrolide Drugs Sales (2020-2031) & (K Units)

Figure 18. Global Macrolide Drugs Average Price (USD/Unit) & (2020-2031)

Figure 19. Macrolide Drugs Report Years Considered

Figure 20. Macrolide Drugs Sales Share by Manufacturers in 2024

Figure 21. Global Macrolide Drugs Revenue Share by Manufacturers in 2024

Figure 22. Global 5 and 10 Largest Macrolide Drugs Players: Market Share by Revenue in Macrolide Drugs in 2024

Figure 23. Macrolide Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 24. Global Macrolide Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 25. North America Macrolide Drugs Sales Market Share by Country (2020-2031)

Figure 26. North America Macrolide Drugs Revenue Market Share by Country (2020-2031)

Figure 27. U.S. Macrolide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Canada Macrolide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Europe Macrolide Drugs Sales Market Share by Country (2020-2031)

Figure 30. Europe Macrolide Drugs Revenue Market Share by Country (2020-2031)

Figure 31. Germany Macrolide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. France Macrolide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. U.K. Macrolide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Italy Macrolide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Russia Macrolide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Asia Pacific Macrolide Drugs Sales Market Share by Region (2020-2031)

Figure 37. Asia Pacific Macrolide Drugs Revenue Market Share by Region (2020-2031)

Figure 38. China Macrolide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Japan Macrolide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. South Korea Macrolide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. India Macrolide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Australia Macrolide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Taiwan Macrolide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Indonesia Macrolide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Thailand Macrolide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Malaysia Macrolide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Philippines Macrolide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Latin America Macrolide Drugs Sales Market Share by Country (2020-2031)

Figure 49. Latin America Macrolide Drugs Revenue Market Share by Country (2020-2031)

Figure 50. Mexico Macrolide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Brazil Macrolide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Argentina Macrolide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Middle East and Africa Macrolide Drugs Sales Market Share by Country (2020-2031)

Figure 54. Middle East and Africa Macrolide Drugs Revenue Market Share by Country (2020-2031)

Figure 55. Turkey Macrolide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Saudi Arabia Macrolide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. U.A.E Macrolide Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. Global Sales Market Share of Macrolide Drugs by Type (2020-2031)

Figure 59. Global Revenue Market Share of Macrolide Drugs by Type (2020-2031)

Figure 60. Global Macrolide Drugs Price (USD/Unit) by Type (2020-2031)

Figure 61. Global Sales Market Share of Macrolide Drugs by Application (2020-2031)

Figure 62. Global Revenue Market Share of Macrolide Drugs by Application (2020-2031)

Figure 63. Global Macrolide Drugs Price (USD/Unit) by Application (2020-2031)

Figure 64. Macrolide Drugs Value Chain

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions